CCR5 is involved in controlling the early stage of Cryptosporidium parvum infection in neonates but is dispensable for parasite elimination

Microbes and Infection

Volumn 10, Issue 4, 2008, Pages 390-395

  Lacroix Lamandé, Sonia ^a   Mancassola, Roselyne ^a   Auray, Gaël ^a   Bernardet, Nelly ^a   Laurent, Fabrice ^a  

^a UR1282   (France)

Author keywords

CCR5; Chemokine; Cryptosporidium parvum; Neonate

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; GAMMA INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; CRYPTOSPORIDIUM PARVUM; DISEASE COURSE; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTOZOAL INFECTION; SENSITIVITY ANALYSIS;

ANIMALS; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; INTERFERON TYPE II; INTESTINES; MICE; RECEPTORS, CCR2; RECEPTORS, CCR5;

CRYPTOSPORIDIUM PARVUM; MUS; PROTOZOA;

EID: 43049144259     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2007.12.020     Document Type: Article

References (19)

1. Mueller A., and Strange P.G. The chemokine receptor, CCR5. Int. J. Biochem. Cell. Biol. 36 (2004) 35-38
2. Algood H.M., and Flynn J.L. CCR5-deficient mice control Mycobacterium tuberculosis infection despite increased pulmonary lymphocytic infiltration. J. Immunol. 173 (2004) 3287-3296
3. Huffnagle G.B., McNeil L.K., McDonald R.A., Murphy J.W., Toews G.B., Maeda N., and Kuziel W.A. Cutting edge: role of C-C chemokine receptor 5 in organ-specific and innate immunity to Cryptococcus neoformans. J. Immunol. 163 (1999) 4642-4646
4. Khan I.A., Thomas S.Y., Moretto M.M., Lee F.S., Islam S.A., Combe C., Schwartzman J.D., and Luster A.D. CCR5 is essential for NK cell trafficking and host survival following Toxoplasma gondii infection. PLoS Pathog. 2 (2006) e49
5. McDonald V. Host cell-mediated responses to infection with Cryptosporidium. Parasite Immunol. 22 (2000) 597-604
6. Theodos C.M., Sullivan K.L., Griffiths J.K., and Tzipori S. Profiles of healing and nonhealing Cryptosporidium parvum infection in C57BL/6 mice with functional B and T lymphocytes: the extent of gamma interferon modulation determines the outcome of infection. Infect. Immun. 65 (1997) 4761-4769
7. Ungar B.L., Kao T.C., Burris J.A., and Finkelman F.D. Cryptosporidium infection in an adult mouse model. Independent roles for IFN-gamma and CD4+ T lymphocytes in protective immunity. J. Immunol. 147 (1991) 1014-1022
8. Lacroix S., Mancassola R., Naciri M., and Laurent F. Cryptosporidium parvum-specific mucosal immune response in C57BL/6 neonatal and gamma interferon-deficient mice: role of tumor necrosis factor alpha in protection. Infect. Immun. 69 (2001) 1635-1642
9. Lacroix-Lamande S., Mancassola R., Naciri M., and Laurent F. Role of gamma interferon in chemokine expression in the ileum of mice and in a murine intestinal epithelial cell line after Cryptosporidium parvum infection. Infect. Immun. 70 (2002) 2090-2099
10. Campbell L.D., Stewart J.N., and Mead J.R. Susceptibility to Cryptosporidium parvum infections in cytokine- and chemokine-receptor knockout mice. J. Parasitol. 88 (2002) 1014-1016
11. Ashton L.J., Stewart G.J., Biti R., Law M., Cooper D.A., and Kaldor J.M. Heterozygosity for CCR5-Δ32 but not CCR2b-64I protects against certain intracellular pathogens. HIV Med. 3 (2002) 91-96
12. Auray G., Lacroix-Lamande S., Mancassola R., Dimier-Poisson I., and Laurent F. Involvement of intestinal epithelial cells in dendritic cell recruitment during C. parvum infection. Microbes Infect. 9 (2007) 574-582
13. Pollok R.C., Farthing M.J., Bajaj-Elliott M., Sanderson I.R., and McDonald V. Interferon gamma induces enterocyte resistance against infection by the intracellular pathogen Cryptosporidium parvum. Gastroenterology 120 (2001) 99-107
14. Leitch G.J., and He Q. Reactive nitrogen and oxygen species ameliorate experimental cryptosporidiosis in the neonatal BALB/c mouse model. Infect. Immun. 67 11 (1999) 5885-5891
15. Wang H.C., Dann S.M., Okhuysen P.C., Lewis D.E., Chappell C.L., Adler D.G., and White Jr. A.C. High levels of CXCL10 are produced by intestinal epithelial cells in AIDS patients with active cryptosporidiosis but not after reconstitution of immunity. Infect. Immun. 75 (2007) 481-487
16. Zlotnik A., and Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 12 (2000) 121-127
17. Sato W., Aranami T., and Yamamura T. Cutting edge: human Th17 cells are identified as bearing CCR2+CCR5- phenotype. J. Immunol. 178 (2007) 7525-7529
18. Quinones M.P., Estrada C.A., Jimenez F., Martinez H., Willmon O., Kuziel W.A., Ahuja S.K., and Ahuja S.S. CCL2-independent role of CCR2 in immune responses against Leishmania major. Parasite Immunol. 29 (2007) 211-217
19. Boring L., Gosling J., Chensue S.W., Kunkel S.L., Farese Jr. R.V., Broxmeyer H.E., and Charo I.F. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J. Clin. Invest. 100 (1997) 2552-2561